DANIEL ERNESTO
CASTELLANO GAUNA
Profesor asociado
University of Chicago
Chicago, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Chicago (5)
2023
-
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
European Urology, Vol. 84, Núm. 3, pp. 321-330
2021
-
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 4, pp. 525-537
2020
-
Long-term outcomes in KEYNOTE-052: Phase II study investigating first-line pembrolizumab in cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer
Journal of Clinical Oncology, Vol. 38, Núm. 23, pp. 2658-2666
-
Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status
European urology oncology, Vol. 3, Núm. 3, pp. 351-359